nach oben

Erschienen in:

Open Access 04.01.2023 | ORIGINAL ARTICLE

LDL-Dependent Regulation of TNFα/PGE₂ Induced COX-2/mPGES-1 Expression in Human Macrophage Cell Lines

verfasst von: Frank Neuschäfer-Rube, Theresa Schön, Ines Kahnt, Gerhard Paul Püschel

Erschienen in: Inflammation | Ausgabe 3/2023

Abstract

Inflammation is a hallmark in severe diseases such as atherosclerosis and non-alcohol-induced steatohepatitis (NASH). In the development of inflammation, prostaglandins, especially prostaglandin E₂ (PGE₂), are major players alongside with chemo- and cytokines, like tumor-necrosis-factor alpha (TNFα) and interleukin-1 beta (IL-1β). During inflammation, PGE₂ synthesis can be increased by the transcriptional induction of the two key enzymes: cyclooxygenase 2 (COX-2), which converts arachidonic acid to PGH₂, and microsomal prostaglandin E2 synthase 1 (mPGES-1), which synthesizes PGE₂ from PGH₂. Both COX-2 and mPGES-2 were induced by a dietary intervention where mice were fed a fatty acid-rich and, more importantly, cholesterol-rich diet, leading to the development of NASH. Since macrophages are the main source of PGE₂ synthesis and cholesterol is predominantly transported as LDL, the regulation of COX-2 and mPGES-1 expression by native LDL was analyzed in human macrophage cell lines. THP-1 and U937 monocytes were differentiated into macrophages, through which TNFα and PGE-2 induced COX-2 and mPGES-1 expression by LDL could be analyzed on both mRNA and protein levels. In addition, the interaction of LDL- and EP receptor signal chains in COX-2/mPGES-1 expression and PGE₂-synthesis were analyzed in more detail using EP receptor specific agonists. Furthermore, the LDL-mediated signal transduction in THP-1 macrophages was analyzed by measuring ERK and Akt phosphorylation as well as transcriptional regulation of transcription factor Egr-1. COX-2 and mPGES-1 were induced in both THP-1 and U937 macrophages by the combination of TNFα and PGE₂. Surprisingly, LDL dose-dependently increased the expression of mPGES-1 but repressed the expression of COX-2 on mRNA and protein levels in both cell lines. The interaction of LDL and PGE₂ signal chains in mPGES-1 induction as well as PGE₂-synthesis could be mimicked by through simultaneous stimulation with EP2 and EP4 agonists. In THP-1 macrophages, LDL induced Akt-phosphorylation, which could be blocked by a PI3 kinase inhibitor. Alongside blocking Akt-phosphorylation, the PI3K inhibitor inhibited LDL-mediated mPGES-1 induction; however, it did not attenuate the repression of COX-2 expression. LDL repressed basal ERK phosphorylation and expression of downstream transcription factor Egr-1, which might lead to inhibition of COX-2 expression. These findings suggest that simultaneous stimulation with a combination of TNFα, PGE₂, and native LDL-activated signal chains in macrophage cell lines leads to maximal mPGES-1 activity, as well repression of COX-2 expression, by activating PI3K as well as repression of ERK/Egr-1 signal chains.

Supplementary file1 (DOCX 157 KB)

Supplementary file2 (DOCX 112 KB)

Supplementary file3 (DOCX 97.3 KB)

Supplementary file4 (DOCX 112 KB)

Supplementary file5 (DOCX 13 KB)

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1007/s10753-022-01778-y.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

COX

Cyclooxygenase

GAPDH

Glycerinaldehyde 3-phosphate dehydrogenase

G protein

Guanine nucleotide-binding protein

EP1-4

Prostaglandin E₂ receptor subtype 1–4

I-κB

Inhibitor of kappaB

IKK

Inhibitor of kappaB kinase

LPS

Lipopolysaccharid

mPGES-1

Microsomal prostaglandin E₂ synthase 1

NF-κB

Nuclear factor-kappa B

PGE₂

Prostaglandin E₂

PKA

Protein kinase A

PKC

Protein kinase C

PI3K

Phosphoinositid 3 Kinase

TNFα

Tumor Necrosis Factor-α

TNFα-R

Tumor Necrosis Factor-α receptor

INTRODUCTION

There is increasing evidence that inflammatory disorders are a hallmark of severe chronic diseases such as atherosclerosis, non-alcohol-induced steatohepatitis (NASH), inflammatory bowel diseases, and rheumatoid arthritis [1‐3]. Inflammation is a complex process with a broad spectrum of mediators been involved such as cytokines, chemokines, and as major players, the prostaglandins [4]. Prostaglandins are formed when the C-20 unsaturated fatty acid arachidonic acid is released from the plasma membrane by phospholipases (PLA_2s). Arachidonic acid is then metabolized by the sequential actions of prostaglandin G/H synthase (cyclooxygenase, COX) and the respective synthases. The cyclooxygenase exists as two distinct enzymes referred to as COX-1 and COX-2. Among these bioactive lipids, PGE₂ is a pivotal prostaglandin that regulates multiple biological processes both under normal and pathological conditions [5]. In addition to its function as key mediator in inflammation, PGE₂ plays a key role in physiologic cellular events such as female reproduction, regulation of vascular tension, kidney and neuronal functions, and gastric mucosal protection. In inflammation, PGE₂ and its specific G protein-coupled EP receptors (EP1-EP4) are involved in the fine tuning of the inflammatory response [6].

Proteins involved in PGE₂ synthesis and signalling have been shown to be increased in inflammation [7]. Thus, the expression of COX-2, mPGES-1, and PGE₂ receptors (EP-R) was increased in inflammatory regions of atherosclerotic plaques of patients with carotid stenosis and the proteins were colocalized in the plaque cells [8]. Dietary lipids, especially cholesterol, are important factors in the progress of inflammation and PGE₂ synthesis. In mice, a high fat/high cholesterol containing diet fat induced a “non-alcohol-induced-steato-hepatitis (NASH)” whereas a high fat diet without cholesterol did not [9‐11]. In the liver of NASH-mice the number of infiltrating macrophages was increased whereas the expression of both COX-2 and mPGES-1 was induced [12]. Dietary cholesterol is transported to the liver from peripheral organs as chylomicron remnants, which are converted to VLDL, IDL, and finally to cholesterol-rich low-density-lipoprotein (LDL). After leaving the liver, LDL may serve as a source for cholesterol in any cell of the body. In addition, LDL can be oxidatively modified in vivo in oxidation events that include phospholipids, fatty acids, and Apo B modifications [13]. Oxidation of LDL can increase its proinflammatory and proatherogenic properties as oxLDL can be taken up by macrophages via scavenger receptors A and B (SR-A and SR-B (CD36) or lectin-like oxLDL receptor (LOX-1) leading to foam cell formation [14]. The knowledge regarding the regulation of COX-2 and mPGES-1 in macrophages by native or oxLDL is limited and sometimes controversial. In primary human macrophages, ox-LDL repressed LPS-induced COX-2 expression [15], whereas in THP-1 macrophages, oxLDL increased COX-2 expression [16]. In the U937 macrophage cell line, the cholesterol oxidation product 27-hydroxycholesterol induced both the expression of COX-2 and mPGES-1 [17]. Little to nothing is known about the regulation of COX-2/mPGES-1 expression by native LDL under inflammatory conditions.

The aim of the current study was to analyze the role of native LDL as a modulator of TNFα/PGE₂-induced COX-2/mPGES-1 expression in human macrophage cell lines.

Our data indicates that native LDL enhanced the TNFα/PGE₂-elicited induction of mPGES-1 in macrophages by an activation of PI3K whereas COX-2 expression was repressed, perhaps due to a reduction of ERK phosphorylation and subsequent repression of Egr-1 expression.

MATERIALS AND METHODS

Materials

All chemicals were purchased from commercial sources indicated throughout the text. Oligonucleotides were custom-synthesized by Biolegio (Nijmegen, Netherlands).

EP receptor specific agonists 19(R)-hydroxy prostaglandin E2 (EP2 agonist), CAY10598 (EP4 agonist), and the PGE₂ ELISA were from Cayman chemicals (Ann Arbor, USA). Antibodies used were GAPDH (sc-2578) and mPGES-1 (sc-365844) from Santa Cruz Biotechnology (Heidelberg, Germany), COX-2 (12282), Akt (9272) and pAkt Ser-473 (4060), ERK (9102), pERK (9106), pIKK α/β Ser176/180 (2694), and cleaved caspase-3 Asp175 (9661) from Cell Signalling (Frankfurt, Germany). Human LDL was purchased from LEE Biosolutions (Maryland Heights, USA).

Cell Culture and Treatment

THP-1 und U937 monocytes were cultured in very low endotoxin RPMI1640 containing 10% heat-inactivated FCS and antibiotics. Monocytes were seeded in 35 mm dishes (10⁶ cells/plate) in culture medium and differentiated to macrophages by the addition of 100 ng/ml PMA for 24 h. Cells were washed two times with serum-free medium and incubated with medium containing 0.5% FCS for another 24 h. Cells were then treated for 24 h, washed two times with PBS and then transferred to liquid nitrogen.

Cell Viability Assay (Alamar Blu)

Cell viability was analyzed by measuring the conversion of non-fluorescent resazurin to fluorescent resorufin by viable THP-1 or U937 macrophages (Alamar Blue assay) [18]. Cells were plated in 96-well plates (10⁵ cells/well) and differentiated to macrophages as described above. After serum-starvation macrophages were stimulated with 50 ng/ml TNFα + 1 µM PGE₂ and increasing LDL-concentrations for 24 h. Then, cells were washed and incubated with 0.1 mg/ml resazurin in RPMI 1640 for 2 h. Resorufin fluorescence was measured every 30 min (Em 544 nm;Exc 590 nm).

MDA Assay

Differentiated THP-1 cells were incubated in culture medium (RPMI 16,040 + 0.5% (v/v) FCS) with or without 500 µg/ml native LDL for 0 h or 24 h at 37 °C. Then, malondialdehyde as a product of lipid peroxidation [19] was measured in cell culture supernatants using a commercial TBARS assay kit (Cayman chemicals, item 10009055) according to the manufacturer’s instructions.

Real-Time RT-PCR

Cells were stimulated with 1 µM PGE₂, 1 µM EP-R agonists and/or 50 ng/ml TNFα in the presence of native human LDL for the time indicated and washed with PBS. Total RNA was isolated from treated cells using Peqgold total RNA kit (Peqlab, Germany). One microgram total RNA were reverse transcribed into cDNA using oligo dT primers and an M-MuLV Reverse Transcriptase (Thermo Scientific, Germany). Hot start real- time PCR for the quantification of each transcript was carried using 2 × Maxima SybrGreen qPCR mix (Thermo Scientific), 0.25 µM of each primer and 2.5 µL of cDNA, which was diluted 1:10. PCR was performed with an initial enzyme activation step at 95 °C for 10 min, followed by 42 cycles of denaturation at 95 °C for 30 s, annealing at 57 °C for 30 s, and extension at 72 °C for 30 s in a real-time DNA thermal cycler (CFX96™, 10 µl reaction volume, BIO-RAD; Munich). The oligonucleotides used are listed in Table 1. The expression level was calculated as an n-fold induction of the gene of interest (int) in treated versus control cells with GAPDH, actin, or HPRT as reference genes (ref). The calculation is based on the differences in the threshold cycles between control (c) and treated (t) groups according to the formula: \(\mathrm{fold \ induction}={2}^{\left(\mathrm{c}-\mathrm{t}\right)\mathrm{int}}/{2}^{\left(\mathrm{c}-\mathrm{t}\right)\mathrm{rev}}\). For the final N-fold calculation, the mean of n-fold calculations using different reference genes was determined. For the calculation of EP-R or COX-1/2 copy numbers of plasmids with cloned cDNAs coding for EP-R, COX-1/2 and GAPDH were used as templates to prepare standard curves with defined copy numbers.

Table 1

Oligonucleotide Primers Used for Real-Time qPCR

Gene	Forward	Reverse
GAPDH	5′-TGATGACATCAAGAAGGTGG	5′-TTACTCCTTGGAGGCCATGT
Actin	5′-CCCAGCCATGTACGTTGCTAT	5′-GGGTGGCTTTTAGGATGGCAA
HPRT	5′-AGGGACTGAACGTCTTGCTCG	5′-ATCCAACACTTCGTGGGGTC
COX-1	5′-CTCCGGTTCTTGCTGTTCCT	5′-GTCACACTGGTAGCGGTCAA
COX-2	5′-TGTGCCTGATGATTGCCCGA CTCC	5′-TGTTGTGTTCCCGCAGCCAGATTG
mPGES-1	5′-GAAGAAGGCCTTTGCCAACCC	5′-GTGCATCCAGGCGACAAAAG
EP1	5′-TCGCTTCGGCCTCCACCTTCTTTG	5′-CGTTGGGCCTCTGGTTGTGCTTAG
EP2	5′-CGAGACGCGACAGTGGCTTCC	5′-CGAGACGCGGCGCTGGTAGA
EP3	5′-CGGGGCTACGGAGGGGATGC	5′-ATGGCGCTGGCGATGAACAACGAG
EP4	5′-TCGCGCAAGGAGCAGAAGGAGACG	5′-GGACGGTGGCGAGAATGAGGAAGG

Accession numbers for the genes were as folles: GAPDH (AB062273), Actin (NM_001101), HPRT (NM_000194), COX-1 (NM_000962), COX-2 (NM_000963), mPGES-1 (NM_025072/NM_198938), EP1 (L22647), EP2 (NM_000956), EP3 (E15918), and EP4 (NM_000958).

PGE₂ ELISA

Cells were stimulated with 1 µM EP2 + EP4 agonists + 50 ng/ml TNFα in the absence or presence of 500 µg/ml native human LDL for 24 h. Then, supernatants were collected and processed for PGE₂ quantification by competitive sandwich ELISA according to the manufacturer’s instructions.

Western Blot Analysis

THP-1 and U937 cells were stimulated with 1 µM PGE₂, 1 µM EP2/EP4-R agonist, and/or 50 ng/ml TNFα in the presence of native human LDL for the time indicated. Cells were lysed in lysis buffer (20 mM Tris pH 7.4, 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid (EDTA), 1 mM ethylene glycol tetraacetic acid (EGTA), 1% (v/v) Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM ß-glycerolphosphate, 50 mM NaF, protease inhibitors, and 1 mM sodium orthovanadate), homogenized by sonication and insoluble material was removed by centrifugation (10,000 × g, 15 min, 4 °C). Protein content was determined using Bradford assay [20]. Proteins were resolved by SDS-PAGE and transferred to a polyvinylidene difluoride (PVDF) membrane. Membranes were blocked in 5% non-fat dry milk in 20 mM Tris, 136 mM NaCl, and 0.1% (v/v) Tween (TBS/Tween) for 1 h at room temperature and incubated with the first antibody in TBS/Tween containing 5% bovine serum albumin overnight at 4 °C and a horseradish-peroxidase-conjugated anti-rabbit or anti-mouse IgG for 2 h at room temperature. Visualization of immune complexes was performed using a Clarity chemiluminescence reagent (BioRad, München).

Statistical Analysis

To correct for differences in sensitivity of different cell charges towards the stimuli, values were normalized to average inducibility defined as the mean of values obtained for as indicated: control, TNFα + PGE₂ and TNFα + PGE₂ + 500 µg/ml LDL-treated cells. Results were analyzed by one- or two-way ANOVA and Tukey’s multicomparison test as indicated in the figure legends.

RESULTS

Regulation of COX-2 and mPGES-1 mRNA and Protein Expression by a Combination of TNFα and PGE₂ and Increasing Concentrations of Native LDL

THP-1 and U937 monocytes were differentiated into macrophages, serum starved for 24 h, and cultured with a combination of TNFα and PGE₂ with increasing concentrations of native LDL for 24 h. PGE₂ and TNFα were used as a proinflammatory stimulus as both molecules are upregulated in inflammatory processes at the same time and in former studies the combination of TNFα and PGE₂ led to maximal induction of the proinflammatory chemokine IL-8 in monocytes [21]. COX-2 and mPGES-1 mRNA expression was measured by real-time PCR (A) and protein expression by Western blot (B). The combination of TNFα and PGE₂ induced COX-2 mRNA expression in THP-1 (4-fold) but only slightly in U937 macrophages (2-fold) (Fig. 1A). Both inductions were statistically not significant. Stimulation with native LDL repressed TNFα + PGE₂-induced COX-2 mRNA expression slightly starting at 10 µg/ml and significantly at concentrations of 500–1000 µg/ml in both cell lines (Fig. 1A). mPGES-1 mRNA expression was induced by a combination of TNFα and PGE₂ in both cell lines (THP-1: 8-fold; U937: 2-fold). Both inductions were not significant. Surprisingly, and in contrast to COX-2 mRNA expression, native LDL increased mPGES-1 mRNA expression in both cell lines significantly at concentrations greater than or equal to 100 µg/ml. The maximal induction was observed at 500 µg/ml (Fig. 1A).

Similar to the regulation of COX-2 mRNA, the combination of TNFα and PGE₂ induced COX-2 protein slightly but not significant in THP-1 and U937 macrophages (2-fold) (Fig. 1B). In line with COX-2 mRNA native LDL dose-dependently decreased COX-2 protein expression both in THP-1 and U937 macrophages. The inhibition was significant with concentrations of 100 µg/ml and above. Maximal inhibition was achieved with 500 µg/ml native LDL. Similar to COX-2, the expression of mPGES-1 was slightly but not significantly induced by the combination of TNFα and PGE₂ in THP-1 and U937 cells (3-fold). In line with the regulation of mPGES-1 mRNA native LDL dose-dependently enhanced mPGES-1 protein expression in both cell lines being maximal at 500 g/ml LDL (THP-1: 2010-fold and U937: 10-fold) (Fig. 1B). In summary, native LDL regulates COX-2 and mPGES-1 in an opposite manner in the two macrophage cell lines: Whereas COX-2 expression was repressed on both the mRNA and the protein levels, mPGES-1 expression was enhanced by native LDL.

Modulation of Cell Viability and Induction of Apoptosis by Increasing LDL Concentrations

As repression of COX-2 and induction of mPGES-1 expression was achieved predominantly at higher LDL-concentrations, cell viability under these conditions was analyzed by cell-dependent resazurin to resorufin conversion (Alamar Blue assay). Induction of apoptosis was determined by capase-3 cleavage in lysates of treated cells. As shown in supplemental Fig. 1, LDL in combination with TNFα and PGE₂ decreased resazurin to resorufin conversion in viable cells at 500 µg/ml and 1000 µg/ml by 20–30% in THP-1 and U937 macrophages. However, this reduction was statistically not significant. Stimulation of THP-1 macrophages with concentration ≥ 100 µg/ml induced caspase-3 cleavage slightly but not significantly (Supplemental Fig. 2). No cleavage was observed in U937 cells. In conclusion, LDL affected COX-2 and mPGES-1 expression already at concentrations that caused no significant reduction of cell viability.

Interaction of Native LDL, TNFα, and PGE₂ in the Regulation of COX-2 and mPGES-1 Expression

To analyze the interaction of native LDL, TNFα, and PGE₂ in the regulation of COX-2 and mPGES-1 expression in more detail, THP-1 and U937 macrophages were stimulated wit 50 µg/ml TNFα and 1 µM PGE₂ alone or in combination in the absence or presence of 500 µg/ml native LDL. Then, COX-2 and mPGES-1 expression was analyzed on the protein level. In THP-1 and U937 macrophages, only the combination of TNFα and PGE₂ significantly induced COX-2 expression whereas mPGES-1 expression by TNFα and PGE₂ was not significant in both cell lines (Fig. 2A, B). Induction of COX-2 protein expression was repressed by 500 µg/ml native LDL in both cell lines. Native LDL alone induced mPGES-1 protein expression significantly in both cell lines (THP-1: 10-fold, U937: 3-fold). This induction was enhanced only by the combination of TNFα and PGE₂ in THP-1 macrophages but not in U937 cells.

In summary, the induction of both enzymes which are important in the production of PGE₂ was maximal by the simultaneous stimulation with TNFα and PGE₂. In THP-1 but not U937 cells, induction of COX-2 and mPGES-1 by PGE₂ seems to be more important than by TNFα. Native LDL modulates this TNFα + PGE₂-mediated enzyme induction in an opposite way: LDL repressed basal and TNFα + PGE₂ induced expression of COX-2 and enhanced basal and induced expression of mPGES-1.

THP-1 and U937 Macrophages Predominantly Expressed EP2 and EP4 Subtype

PGE₂ acts upon a family of four different G-protein-coupled receptors called EP1 to EP4. To analyze which EP-R subtype might be involved in the induction of the LDL-modulated COX-2 and mPGES-1 induction by PGE₂ in the macrophage cell lines, EP-R mRNA in these cells was quantified by real-time RT-PCR. To estimate exact EP-R mRNA copies, standard curves with plasmids containing defined copies of EP-R or GAPDH cDNA were prepared. EP2 mRNA was most abundant in both cell lines and was twice the expression of EP4 (Table 2). EP1 and EP3 mRNAs expression levels were very low in both macrophage cell lines. All EP mRNAs were expressed in THP-1 and U937 macrophages to a comparable level. It was, therefore, most likely that the PGE₂-dependent induction of COX-2 and mPGES-1 expression was mediated via EP2 and EP4 receptors.

Table 2

EP-R mRNA Profile in THP-1 and U937 Macrophages

Cells	EP1	EP2	EP3	EP4
THP-1	0.03 ± 0.03	144.91 ± 66.97	5.62 ± 2.1	68.29 ± 17.36
U937	0.001 ± 0.0001	121 ± 35.95	2.49 ± 0.63	54.63 ± 14.35

THP-1 and U937 cells were differentiated and cultured as described in the legend to Fig. 1. EP-R mRNA and GAPDH mRNA of control cells was measured by real-time RT-qPCR as described in the “MATERIALS AND METHODS” section. Plasmids (10²–10⁸ copies) containing EP-R or GAPDH cDNAs were used for preparing standard curves for the calculation of EP-R or GAPDH mRNA copy numbers. Data represent the mean ± SEM of at least five independent RNA preparations. EP-R mRNA contents are expressed as copy number EP-R mRNA × 1000/copy number GAPDH mRNA.

Interaction of EP2/EP4 Agonists, TNFα, and Native LDL, in the Regulation of COX-2 and mPGES-1 Expression and PGE₂-synthesis in THP-1 Macrophages

Since the regulation of COX-2 and mPGES-1 protein expression by TNFα and PGE₂ and native LDL, as well EP-R expression was similar in THP-1 and U937 macrophages, all further experiments were performed solely on THP-1 cells. As the expression of EP1 and EP3 was very low in THP-1 cells, it was analyzed whether EP2 and or EP4 receptor agonists can mimic the effect of PGE₂ in the regulation of COX-2 and mPGES-1 expression. THP-1 macrophages were stimulated with 50 µg/ml TNFα and either 1 µM of EP2 and EP4-agonist alone or in combination or 1 µM PGE₂ and 50 ng/ml TNFα in the absence or presence of 500 µg/ml native LDL for 24 h. Then, COX-2 and mPGES-1 protein expression was analyzed. COX-2 expression was significantly induced to a similar level by TNFα in combination with the EP4-agonist alone, the combination of EP2/EP4-agonists and PGE₂ (2-fold), but not in combination with the EP2-agonist alone (Fig. 3A). COX-2 expression, induced by the different combinations of stimuli, was significantly repressed by native LDL. The expression of mPGES-1 was also induced by TNFα in combination with the EP4-agonist alone, the combination of EP2/EP4-agonists and PGE₂ (twofold) but to a lower level in combination with the EP2-agonist alone (Fig. 3B). However, these inductions were not significant. In combination with native LDL, TNFα and the EP4- but not the EP2-agonist significantly induced mPGES-1 expression to a comparable level as the stimulation with TNFα and PGE₂. However, maximal mPGES-1 expression was induced with the combination of native LDL, TNFα, and both EP2/EP4-agonist.

The results show that COX-2 and mPGES-1 expression were induced in THP-1 cells by PGE₂ mainly via EP4 receptor signal chains and that LDL can repress the signal chains leading to COX-2 expression and enhance the signal chains leading to mPGES-1 expression.

Next, it was analyzed how PGE₂-synthesis was regulated by EP2/EP4-agonists, TNFα, and native LDL. As observed for mPGES-1 mRNA and protein expression stimulation of THP-1 macrophages with EP2/EP4-agonists and TNFα as well as 500 µg/ml native LDL induced PGE₂-synthesis to a comparable level (3-fold, Fig. 4). PGE₂-synthesis was highest after simultaneous stimulation with EP2/4-agonist and TNFα and native LDL (6-fold). Therefore, PGE₂-synthesis showed the same regulation pattern as mPGES-1 expression.

Inhibition of LDL-Mediated Induction of mPGES-1 Expression by the PI3K Inhibitor LY294004

Expression of COX-2 and mPGES-1, which are the key enzymes in inflammation-induced PGE₂ synthesis, is usually induced in concert by proinflammatory stimuli such as LPS and IL-1β by activation of transcription factor NFκB [22, 23]. An uncoupled expression of the two enzymes was described in primary rat microglia cells. In these cells, the PI3K inhibitors LY294002 or NVP-BEZ235 inhibited LPS-induced mPGES-1 expression and enhanced LPS-induced COX-2 expression [24, 25]. To analyze whether PI3K is also involved in the LDL-mediated repression of COX-2 vs. induction of mPGES-1, THP-1 macrophages were incubated with 10 µM or 50 µM LY294002 30 min before and during the stimulation with the combination of 50 ng/ml TNFα and 1 µM PGE₂ in the absence or presence of 500 µM native LDL. Then, COX-2 and mPGES-1 expression was determined by Western blot. Preincubation with 10 µM LY294002 significantly reduced induction of mPGES-1 expression by the combination of TNFα and PGE₂ in the presence of LDL (Fig. 5B). By contrast, LY294002 had no effect on the LDL-induced repression of COX-2 expression (Fig. 5A). In conclusion, PI3K may be involved in the LDL-mediated induction of mPGES-1 but not in the repression of COX-2.

LDL-Mediated Activation of Akt-Kinase in THP-1 Macrophages

As inhibition of PI3K repressed LDL-mediated induction of mPGES-1 in THP-1 macrophages, this point to a direct activation of PI3K by native LDL. A down-stream target substrate of activated PI3K is the Akt-kinase, which is activated by PI3K-mediated phosphorylation. Therefore, LDL-mediated Akt phosphorylation was analyzed by Western blot using a phospho-specific Akt antibody. Stimulation of THP-1 macrophages with 500 µg/ml native LDL for 10 min led to significant Akt-phosphorylation which was constant at 30 and 60 min and was not effected by simultaneous stimulation with TNFα and 1 µM PGE₂ (Fig. 6A). In addition, a significant LDL-mediated Akt phosphorylation was also measured at the end of the 24 h LDL stimulation period and was suppressed by the PI3K inhibitor LY294002 (Fig. 6B). In conclusion, LDL-mediated induction of mPGES-1 expression is most likely a result of LDL-mediated PI3K activation.

LDL-Mediated Inhibition of Egr-1 Expression and ERK-Phosphorylation

In contrast to rat microglia cells, where PI3K inhibitors simultaneously induced COX-2 and repressed mPGES-1 expression, LY294002 did not reverse LDL-mediated repression of COX-2 expression. So, there is some evidence that native LDL repressed COX-2 through other signal chains. An important transcription factor which positively controls both COX-2 and mPGES-1 expression is the transcription factor early growth response protein 1 (Egr-1) [23, 26]. Egr-1 is induced by proinflammatory stimuli such as LPS or IL-1β [23, 27]. So, next it was examined whether native LDL can modulate Egr-1 expression. Egr-1 mRNA expression was not modulated by stimulation with the combination of TNFα and PGE₂. By contrast, 500 µg/ml native LDL significantly repressed Egr-1 mRNA expression both in control and TNFα and 1 µM PGE₂ stimulated THP-1 macrophages (Fig. 7A). Besides the induction of Egr-1 expression by proinflammatory stimuli, Egr-1 expression is also controlled by extracellular-signal regulated kinase ERK which is activated by phosphorylation and deactivated through dephosphorylation. Through Western blotting with a phospho-secific ERK antibody, it was determined that native LDL can modulate the phosphorylation status of ERK. Similar to Egr-1 mRNA expression, the basal phosphorylation of ERK, which was uninspected high in PMA-treated, serum-starved THP-1 cells, was not influenced by stimulation with the combination of TNFα and PGE₂ but was significantly repressed by stimulation with 500 µg/ml native LDL for 24 h (Fig. 7B). Therefore, it was assumed that LDL-mediated repression of COX-2 was a result of LDL-mediated repression of ERK phosphorylation and Egr-1 expression.

LDL-Mediated Modulation of NFκB Signalling

Coordinated expression of COX-2 and mPGES-1 by LPS and IL-1β is mainly controlled by transcription factor NFκB [23]. One of the important steps in NFκB activation is the activation of IKK by phosphorylation. Then, phosphorylated IKK can phosphorylate IκB which leads to its ubiquitinylation and proteasomal degradation and NFκB activation. Therefore, we measured IKK phosphorylation by TNFα + PGE₂ and increasing concentrations of LDL in lysates of THP-1 macrophages by western blot. As shown in Supplemental Fig. 3 treatment with TNα + PGE₂ increased the amount of pIKK slightly but not significantly. IKK phosphorylation was marginally and also not significantly repressed by increasing LDL concentrations. So, activation of NFκB signal chain seems not to be involved in the LDL-mediated regulation of COX-2 and mPGES-1 expression.

DISCUSSION

This current study showed that simultaneous activation of TNFα-R and EP2/EP4 signal chains induced COX-2 and mPGES-1 mRNA and protein expression in the macrophage cell lines THP-1 and U937. Surprisingly, native LDL repressed COX-2 expression and markedly enhanced mPGES-1 as well as PGE₂ synthesis. In THP-1 cells, LDL-mediated induction of mPGES-1 expression was most likely induced by PI3K activation, whereas COX-2 repression may be a functional consequence of reduced ERK phosphorylation and expression of transcription factor Egr-1.

Role of Native LDL in the Inflammatory Response

A hallmark of the development of atherosclerosis is the uptake of modified LDL, which undergoes spontaneous oxidation or modification, by macrophages via scavenger receptors such as CD36 or SR-A, resulting in the formation of foam cells. Beside foam cell formation, oxidized LDL also triggers a chronic inflammatory response, which is a confirmed main cause of plaque rupture and thrombosis [28]. Macrophages in atherosclerotic lesions are key players in the inflammatory process as they produce proinflammatory cytokines and eicosanoids [29]. Only little is known about the function of native LDL in atherosclerotic inflammatory response. Different from oxidized LDL, native LDL is bound and internalized by the LDL-R. Its expression is under tight control of the intracellular cholesterol concentration: an increase in cellular cholesterol downregulates LDL-R expression via a negative feedback loop [30].

Interestingly, most studies that analyzed the influence of native LDL on the inflammatory response in macrophages showed that native LDL rather inhibited than enhanced inflammation. In THP-1 macrophages, native LDL dose-dependently inhibited the serum amyloid A (SAA), induced IL-1β and TNFα expression, most likely by inhibiting NLRP3 inflammosome activation by SAA [31]. A mixture of native LDL, VLDL, and HDL (VLR) also inhibited the basal expression of several inflammatory genes such as IL-6, IL1β, and IL-23A [32]. By contrast to the inhibition of SAA-induced inflammation, the authors of this study postulated that native LDL inhibited expression of inflammatory genes by hypermethylation of their promotor region, whereas LDL had no effect on histone acetylation. In line with these two reports, degradation of the LDL-R in THP-1 macrophages by PCSK9 led to a proinflammatory response, inducing the expression of the proinflammatory cytokines IL-1β, TNFα, MCP-1, and CXCL2 [33].

The aim of the current study was to analyze whether native LDL can modulate the expression of COX-2 and mPGES-1. However, although the experiments were performed with purified, native LDL, spontaneous oxidation during the experiment cannot be entirely excluded. Thus, we determined the oxidation status of the native LDL using malondialdehyde (MDA) assay as an indicator of lipid peroxidation (Supplemental Fig. 4). Whereas MDA was not detectable in the culture medium, the addition of 500 µg/ml LDL, which was not actively modified by chemical oxidation, significantly increased MDA concentration. MDA concentration was markedly enhanced by 24-h incubation with THP-1 macrophages (5-fold). It can, therefore, not be excluded that oxidized LDL also contributed to the regulation of COX-2 and mPGES-1.

The effect of mPGES-1 expression on the development of inflammatory disease as atherosclerosis was analyzed using mPGES-1 knockout mice. Global deletion of mPGES-1 in an LDL-R (-/-), fat-fed model slows atherogenesis, which is indicated by a reduced plaque burden and a reduced number of macrophage foam cells in atherosclerotic lesions [34]. Cell-specific deletion of the mPGES-1 revealed that PGE₂ formation in macrophages appears to be essential in this process: Mice lacking mPGES-1 expression in myeloid cells showed markedly reduced atherogenesis in an LDL-R (-/-), high fat-fed model, whereas depletion of mPGES-1 in vascular-smooth muscle or endothelial cells did not alter development of atherosclerosis in this mouse model [35]. These results implicate, that the LDL-mediated induction of mPGES-1 expression (Fig. 1) and enhanced PGE₂-secretion (Fig. 4) observed in the current study might increase development of atherosclerosis, especially in combination with other inflammatory mediators such as TNFα and PGE₂ which induced maximal expression of the chemotactic cytokine IL-8 in monocytic cell lines and PBMC [21].

Increase of PGE₂-synthesis After LDL-Mediated Concomitant mPGES-1 Induction and COX-2 Repression

For an effective synthesis of PGE₂, in most cases, the expression of mPGES-1, which generate PGE₂ from PGH₂, is functionally coupled to expression of COX-2, which provide PGH₂ by conversion of arachidonic acid. Coordinated induction of expression of COX-2 and mPGES-1 by pro-inflammatory stimuli such as IL-1β, TNFα, or LPS, activating transcription factor NFκB or PGE₂, via activation of transcription factor CREB was observed in macrophages [36]. In the current study, native LDL markedly decreased COX-2 but enhanced mPGES-1 expression, both induced by the combination of TNFα and PGE₂. Native LDL stimulated PGE₂ synthesis and enhanced PGE₂-synthesis induced by the combination of TNFα andEP2/EP4 agonists. Since LDL repressed COX-2 the question arose, which pathway might furnish PGH₂ as substrate for the subsequent mPGES-1 reaction? One possible explanation might be the high constitutive expression of COX-1 in THP-1 cells (Table 3). In the current study, the COX-1 mRNA copy numbers in naive or TNFα and PGE₂ stimulated THP-1 macrophages were comparable to COX-2 mRNA (Table 3). A robust COX-1 expression in THP-1 macrophages was also confirmed in other publications [37, 38]. Therefore, COX-1 rather than COX-2 may generate PGH₂ in THP-1 macrophages, which was converted to PGE₂ by LDL-induced mPGES-1.

Table 3

COX mRNA Profile in THP-1 Macrophages

COX-1 Control	COX-1 TNFα + PGE₂	COX-2 Control	COX-2 TNFα + PGE₂
3.14 ± 1.27	6.09 ± 1.97	2.48 ± 1.57	11.9 ± 4.29

THP-1 cells were differentiated and cultured as described in the legend to Fig. 1. COX mRNA and GAPDH mRNA of control and TNFα + PGE₂-stimulated cells was measured by real-time RT-qPCR as described in the “MATERIALS AND METHODS” section. Plasmids (10²–10⁸ copies) containing COX or GAPDH cDNAs were used for preparing standard curves for the calculation of COX or GAPDH mRNA copy numbers. Data represent the mean ± SEM of at least five independent RNA preparations. COX mRNA contents are expressed as copy number COX/PGES mRNA × 1000/copy number GAPDH mRNA.

LDL-Stimulated Signal Chains Leading to Induction of mPGES-1 Expression and Repression of COX-2 Expression

In the current study, native LDL repressed the induction of TNFα + PGE₂-induced COX-2 expression and simultaneously enhanced the expression of mPGES-1 (Fig. 1). Most studies analyzing the regulation of COX-2 and mPGES-1 expression show a coordinated expression of both enzymes. Expression of both enzymes in macrophages were induced by LPS or IL-1β mediated activation of transcription NFκB as well as PGE₂-mediated CREB activation [23, 36]. A simultaneous induction of COX-2 and mPGES-1 was also found by activation of the NLRP3 inflammasome [39] and by LPS [40]. By contrast, COX-2 and mPGES-1 expression in rat glia cells were regulated in an uncoupled way using inhibitors of PI3K. Whereas LPS-induced COX-2 expression was enhanced by stimulation of PI3K, LPS-induced expression of mPGES-1 was repressed, leading to an overall reduction of PGE₂ and an induction of PGD₂-release [24, 25]. To prove whether LDL-mediated repression of COX-2 and enhanced expression of mPGS-1 was due to an activation of PI3K, activation of the kinase by LDL was analyzed measuring phosphorylation of the PI3K substrate Akt kinase (Fig. 6) as well as using a PI3K inhibitor (Fig. 5). In line with this hypothesis first, stimulation of THP-1 macrophages led to a phosphorylation of Akt kinase (Fig. 6) and secondly, the LDL-mediated enhancement of mPGES-1 expression was completely blocked in THP-1 cells using the pan PI3K inhibitor LY294002 (Fig. 5). These data strongly indicate, for the first time, that native LDL enhanced mPGES1 expression in activated macrophages by a PI3K-dependent signal chain. An LDL-mediated activation of Akt kinase was also described in human endothelial cells [41]. In these cells, native LDL activated a PI3K-Akt-mTOr signalling pathway most likely by the formation of an LDL-R/ insulin receptor complex. Activation of this signal chain led to an LDL-mediated, insulin-mimetic glucose uptake in the endothelial cells.

By contrast to mPGES-1 expression, the PI3K inhibitor did not influence LDL-mediated repression of COX-2 expression in activated THP-1 macrophages. One of the key factors in the induction of COX-2 expression is the transcription factor Egr-1, which is transcriptionally controlled by an activated ERK kinase [42, 43]. The current study indicated that native LDL repressed Egr-1 expression and abolished ERK phosphorylation in THP-1 macrophages (Fig. 7) which may explain the repression of COX-2 expression by LDL.

These findings suggest, for the first, time that in human macrophage cell lines LDL simultaneously repressed COX-2 and enhanced mPGES-1 expression induced by TNFα and PGE₂ signal chains, most likely by inactivating pERK as well as activating PI3K (Fig. 8).

Declarations

Conflict of Interest

The authors declare no competing interests.

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Jetzt e.Med zum Sonderpreis bestellen!

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Jetzt bestellen und 100 € sparen!

Jetzt testen ¹

e.Dent – Das Online-Abo der Zahnmedizin

Online-Abonnement

Mit e.Dent erhalten Sie Zugang zu allen zahnmedizinischen Fortbildungen und unseren zahnmedizinischen und ausgesuchten medizinischen Zeitschriften.

Jetzt testen ²

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

Jetzt bestellen und 100 € sparen!

Jetzt testen ³

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 157 KB)

Supplementary file2 (DOCX 112 KB)

Supplementary file3 (DOCX 97.3 KB)

Supplementary file4 (DOCX 112 KB)

Supplementary file5 (DOCX 13 KB)

Furman, D., J. Campisi, E. Verdin, P. Carrera-Bastos, S. Targ, C. Franceschi, L. Ferrucci, and W. Gilroy D, Fasano A, Miller GW, Miller AH, Mantovani A, Weyand CM, Barzilai N, Goronzy JJ, Rando TA, Effros RB, Lucia A, Kleinstreuer N, Slavich GM,. 2019. Chronic inflammation in the etiology of disease across the life span. Nature Medicine. https://doi.org/10.1038/s41591-019-0675-0.CrossRefPubMedPubMedCentral

Bennett, J.M., G. Reeves, G.E. Billman, and J.P. Sturmberg. 2018. Inflammation-nature’s way to efficiently respond to all types of challenges: Implications for understanding and managing “the epidemic” of chronic diseases. Frontiers in Medicine (Lausanne).

Kotas, M.E., and R. Medzhitov. 2015. Homeostasis, inflammation, and disease susceptibility. Cell. https://doi.org/10.1016/j.cell.2015.02.010.

Yao, C., and S. Narumiya. 2019. Prostaglandin‐cytokine crosstalk in chronic inflammation. British Journal of Pharmacology. https://doi.org/10.1111/bph.14530.

Narumiya, S. 2007. Physiology and pathophysiology of prostanoid receptors. Proceedings of the Japan Academy Series B: Physical and Biological Sciences. https://doi.org/10.2183/pjab/83.296.

Tsuge, K., T. Inazumi, A. Shimamoto, and Y. Sugimoto. 2019. Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases. International Immunology. https://doi.org/10.1093/intimm/dxz021.

Linton, M.F., and S. Fazio. 2004. Cyclooxygenase-2 and inflammation in atherosclerosis Current Opinion in Pharmacology 4: 116–123. https://doi.org/10.1016/j.coph.2003.12.003.

Gómez-Hernández, A., J.L. Martín-Ventura, E. Sánchez-Galán, C. Vidal, M. Ortego, L.M. Blanco-Colio, L. Ortega, L. Tuñón, and J. Egido. 2006. Overexpression of COX-2, prostaglandin E synthase-1 and prostaglandin E receptors in blood mononuclear cells and plaque of patients with carotid atherosclerosis: Regulation by nuclear factor-kappaB. Atherosclerosis 187: 139–149. https://doi.org/10.1016/j.atherosclerosis.2005.08.035.CrossRefPubMed

Henkel, J., C.D. Coleman, A. Schraplau, K. Jöhrens, D. Weber, J.P. Castro, M. Hugo, T.J. Schulz, S. Krämer, A. Schürmann, and G.P. Püschel. 2017. Induction of steatohepatitis (NASH) with insulin resistance in wild-type B6 mice by a Western-type diet containing soybean oil and cholesterol. Molecular Medicine 23: 70–82. https://doi.org/10.2119/molmed.2016.00203.

10.

Henkel, H., E. Alfine, J. Saín, K. Jöhrens, D. Weber, J.P. Castro, J. König, C. Stuhlmann, M. Vahrenbrink, W. Jonas, A. Kleinridders, and G.P. Püschel. 2018. Soybean oil-derived poly-unsaturated fatty acids enhance liver damage in NAFLD induced by dietary cholesterol. Nutrients 10: 1326. https://doi.org/10.3390/nu10091326.CrossRefPubMedPubMedCentral

11.

Püschel, G.P., and J. Henkel. 2019. Dietary cholesterol does not break your heart but kills your liver. Porto Biomedical Journal 29: 12. https://doi.org/10.1016/j.pbj.0000000000000012.CrossRef

12.

Henkel, J., C.D. Coleman, Jöhrens. K. Schraplau, T.S. Weiss, W. Jonas, A. Schürmann, and G.P. Püschel. 2018. Augmented liver inflammation in a microsomal prostaglandin E synthase 1 (mPGES-1)-deficient diet-induced mouse NASH model. Science and Reports 8: 16127. https://doi.org/10.1038/s41598-018-34633-y.CrossRef

13.

Parthasarathy, S., A. Raghavamenon, M.O. Garelnabi, and N. Santanam. 2010. Oxidized low-density lipoprotein. Methods in Molecular Biology 610: 403–417. https://doi.org/10.1007/978-1-60327-029-8_24.CrossRefPubMed

14.

Lara-Guzmán, O.J., Á. Gil-Izquierdo, S. Medina, E. Osorio, R. Álvarez-Quintero, N. Zuluaga, C. Oger, J.M. Galano, T. Durand, and K. Muñoz-Durango. 2018. Oxidized LDL triggers changes in oxidative stress and inflammatory biomarkers in human macrophages. Redox Biology 15: 1–11. https://doi.org/10.1016/j.redox.2017.11.017.CrossRefPubMed

15.

Eligini, S., S. Colli, F. Basso, L. Sironi, and E. Tremoli. 1999. Oxidized low density lipoprotein suppresses expression of inducible cyclooxygenase in human macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 19: 1719–1722. https://doi.org/10.1161/01.atv.19.7.1719.CrossRefPubMed

16.

Wang, L., J.W. Xia, Z.P. Ke, and B.H. Zhang. 2019. Blockade of NEAT1 represses inflammation response and lipid uptake via modulating miR-342–3p in human macrophages THP-1 cells. Journal of Cellular Physiology 234: 5319–5326. https://doi.org/10.1002/jcp.27340.

17.

Gargiulo, S., D. Rossin, G. Testa, P. Gamba, E. Staurenghi, F. Biasi, G. Poli, and G. Leonarduzzi. 2018. Up-regulation of COX-2 and mPGES-1 by 27-hydroxycholesterol and 4-hydroxynonenal: A crucial role in atherosclerotic plaque instability. Free Radical Biology & Medicine 129: 354–363. https://doi.org/10.1016/j.freeradbiomed.2018.09.046.CrossRef

18.

Rampersad, S.N. 2012. Multiple applications of Alamar Blue as an indicator of metabolic function and cellular health in cell viability bioassays. Sensors (Basel) 12: 12347–12360. https://doi.org/10.3390/s120912347.CrossRefPubMed

19.

Yagi, K. 1998. Simple assay for the level of total lipid peroxides in serum or plasma. Methods in Molecular Biology 108: 101–106. https://doi.org/10.1385/0-89603-472-0:101.CrossRefPubMed

20.

Kielkopf, C.L., W. Bauer, and I.L. Urbatsch. 2020. Bradford assay for determining protein concentration. Cold Spring Harbor Protocols 4: 102269. https://doi.org/10.1101/pdb.prot102269.

21.

Neuschäfer-Rube, F., A. Pathe-Neuschäfer-Rube, S. Hippenstiel, and G.P. Püschel. 2019. PGE2 enhanced TNFα-mediated IL-8 induction in monocytic cell lines and PBMC. Cytokine 113: 105–111. https://doi.org/10.1016/j.cyto.2018.06.020.CrossRefPubMed

22.

Farley, J., J. Sirois, P.H. MacFarlane, A. Kombé, and S. Laverty. 2005. Evaluation of coexpression of microsomal prostaglandin E synthase-1 and cyclooxygenase-2 in interleukin-1-stimulated equine articular chondrocytes. American Journal of Veterinary Research 66: 1985–1989. https://doi.org/10.2460/ajvr.2005.66.1985.CrossRefPubMed

23.

Díaz-Muñoz, M.D., I.C. Osma-García, C. Cacheiro-Llaguno, M. Fresno, and M.A. Iñiguez. 2010. Coordinated up-regulation of cyclooxygenase-2 and microsomal prostaglandin E synthase 1 transcription by nuclear factor kappa B and early growth response-1 in macrophages. Cellular Signalling 22: 1427–1436. https://doi.org/10.1016/j.cellsig.2010.05.011.CrossRefPubMed

24.

de Oliveira, A.C., E. Candelario-Jalil, H.S. Bhatia, K. Lieb, M. Hüll, and B.L. Fiebich. 2008. Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: evidence for uncoupled regulation of mPGES-1 and COX-2. Glia 56: 844–55. https://doi.org/10.1002/glia.20658.

25.

de Oliveira, A.C., E. Candelario-Jalil, J. Langbein, L. Wendeburg, H.S. Bhatia, J.C. Schlachetzki, K. Biber, and B.L. Fiebich. 2012. Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microglia. Journal of Neuroinflammation 3: 2. https://doi.org/10.1186/1742-2094-9-2.CrossRef

26.

Guillem-Llobat, P., and M.A. Íñiguez. 2015. Inhibition of lipopolysaccharide-induced gene expression by liver X receptor ligands in macrophages involves interference with early growth response factor 1. Prostaglandins Leukotrienes and Essential Fatty Acids 96: 37–49. https://doi.org/10.1016/j.plefa.2015.02.002.CrossRefPubMed

27.

Sanchez-Guerrero, E., E. Chen, M. Kockx, S.W. An, B.H. Chong, and L.M. Khachigian. 2012. IL-1beta signals through the EGF receptor and activates Egr-1 through MMP-ADAM. PLoS ONE 7: e39811. https://doi.org/10.1371/journal.pone.0039811.CrossRefPubMedPubMedCentral

28.

Hansson, G.K., P. Libby, and I. Tabas. 2015. Inflammation and plaque vulnerability. Journal of Internal Medicine 278: 483–493. https://doi.org/10.1111/joim.12406.CrossRefPubMedPubMedCentral

29.

Hansson, G.K., and A. Hermansson. 2011. The immune system in atherosclerosis. Nature Immunology 12: 204–212. https://doi.org/10.1038/ni.2001.CrossRefPubMed

30.

Dawson, P.A., S.L. Hofmann, D.R. van der Westhuyzen, T.C. Südhof, M.S. Brown, and J.L. Goldstein. 1988. Sterol-dependent repression of low density lipoprotein receptor promoter mediated by 16-base pair sequence adjacent to binding site for transcription factor Sp1. Journal of Biological Chemistry 263: 3372–3379.CrossRefPubMed

31.

Nurmi, K., K. Niemi, I. Kareinen, K. Silventoinen, M.B. Lorey, Y. Chen, V.P. Kouri, J. Parantainen, T. Juutilainen, K. Öörni, P.T. Kovanen, D. Nordström, S. Matikainen, and K.K. Eklund. 2011. Native and oxidised lipoproteins negatively regulate the serum amyloid A-induced NLRP3 inflammasome activation in human macrophages. Clinical & Translational Immunology 10. https://doi.org/10.1002/cti2.1323.

32.

Rangel-Salazar, R., M. Wickström-Lindholm, C.A. Aguilar-Salinas, Y. Alvarado-Caudillo, K. Døssing, M. Esteller, E. Labourier, G. Lund, F.C. Nielsen, D. Rodríguez-Ríos, M.O. Solís-Martínez, K. Wrobel, K. Wrobel, and S. Zaina. 2021. Human native lipoprotein-induced de novo DNA methylation is associated with repression of inflammatory genes in THP-1 macrophages. BMC Genomics 25: 582. https://doi.org/10.1186/1471-2164-12-582.CrossRef

33.

Ricci, C., M. Ruscica, M. Camera, L. Rossetti, C. Macchi, A. Colciago, I. Zanotti, M.G. Lupo, M.P. Adorni, A.F.G. Cicero, F. Fogacci, A. Corsini, and N. Ferri. 2018. PCSK9 induces a pro-inflammatory response in macrophages. Science and Reports 8: 2267. https://doi.org/10.1038/s41598-018-20425-x.CrossRef

34.

Wang, M., A. Zukas, Y. Hui, E. Ricciotti, E. Puré, and G.A. FitzGerald. 2006. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis. Proceedings of the National Academy of Sciences 103: 14507–14512. https://doi.org/10.1073/pnas.0606586103.CrossRef

35.

Chen, L., G. Yang, J. Monslow, L. Todd, D.P. Cormode, J. Tang, G.R. Grant, J.H. DeLong, S.Y. Tang, J.A. Lawson, E. Pure, and G.A. Fitzgerald. 2014. Myeloid cell microsomal prostaglandin E synthase-1 fosters atherogenesis in mice. Proceedings of the National Academy of Sciences U S A 111: 6828–6833. https://doi.org/10.1073/pnas.1401797111.CrossRef

36.

Díaz-Muñoz, M.D., I.C. Osma-García, M. Fresno, and M.A. Iñiguez. 2012. Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages. The Biochemical Journal 443: 451–461. https://doi.org/10.1042/BJ20111052.CrossRefPubMed

37.

Smith, C.J., J.D. Morrow, L.J. Roberts 2nd., and L.J. Marnett. 1993. Differentiation of monocytoid THP-1 cells with phorbol ester induces expression of prostaglandin endoperoxide synthase-1 (COX-1). Biochemical and Biophysical Research Communications 192: 787–793. https://doi.org/10.1006/bbrc.1993.1483.CrossRefPubMed

38.

Korbecki, J., I. Baranowska-Bosiacka, I. Gutowska, K. Piotrowska, and D. Chlubek. 2015. Cyclooxygenase-1 as the main source of proinflammatory factors after sodium orthovanadate treatment. Biological Trace Element Research 163: 103–111. https://doi.org/10.1007/s12011-014-0176-4.CrossRefPubMed

39.

Zhuang, Y., F. Zhao, J. Liang, X. Deng, Y. Zhang, G. Ding, A. Zhang, Z. Jia, and S. Huang. 2017. Activation of COX-2/mPGES-1/PGE2 cascade via NLRP3 inflammasome contributes to albumin-induced proximal tubule cell injury. Cellular Physiology and Biochemistry 42: 797–807. https://doi.org/10.1159/000478070.CrossRefPubMed

40.

Font-Nieves, M., M.G. Sans-Fons, R. Gorina, E. Bonfill-Teixidor, A. Salas-Pérdomo, L. Márquez-Kisinousky, T. Santalucia, and A.M. Planas. 2012. Induction of COX-2 enzyme and down-regulation of COX-1 expression by lipopolysaccharide (LPS) control prostaglandin E2 production in astrocytes. Journal of Biological Chemistry 287: 6454–6456. https://doi.org/10.1074/jbc.M111.327874.CrossRefPubMedPubMedCentral

41.

Zhu, L., G. Wu, X. Yang, X. Jia, J. Li, X. Bai, W. Li, Y. Zhao, Y. Li, W. Cheng, S. Liu, and S. Jin. 2019. Low density lipoprotein mimics insulin action on autophagy and glucose uptake in endothelial cells. Science and Reports 28: 3020. https://doi.org/10.1038/s41598-019-39559-7.CrossRef

42.

Takuya, T., F. Zhang, L. Sun, F. Hao, C. Schmitz-Peiffer, X. Xu, and M.Z. Cui. 2012. Lysophosphatidic acid induces early growth response-1 (Egr-1) protein expression via protein kinase Cδ-regulated extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) activation in vascular smooth muscle cells. Journal of Biological Chemistry 287: 22635–22642. https://doi.org/10.1074/jbc.M111.335695.CrossRef

43.

Pagel, J.I., and E. Deindl. 2012. Disease progression mediated by egr-1 associated signaling in response to oxidative stress. International Journal of Molecular Sciences 13: 13104–13117. https://doi.org/10.3390/ijms131013104.CrossRefPubMedPubMedCentral

Titel: LDL-Dependent Regulation of TNFα/PGE2 Induced COX-2/mPGES-1 Expression in Human Macrophage Cell Lines
verfasst von: Frank Neuschäfer-Rube
Theresa Schön
Ines Kahnt
Gerhard Paul Püschel
Publikationsdatum: 04.01.2023
Verlag: Springer US
Erschienen in: Inflammation / Ausgabe 3/2023
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI: https://doi.org/10.1007/s10753-022-01778-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

LDL-Dependent Regulation of TNFα/PGE₂ Induced COX-2/mPGES-1 Expression in Human Macrophage Cell Lines

Abstract

Supplementary Information

Publisher's Note

INTRODUCTION